Although we ca hypothesize that single or multiple infusions of CXCR4-IL10-MSCs might also exert improved long-term responses in patients with either acute or chronic GvHD, further experimental studies will be required to confirm this hypothesis. The gene discussed is CXCR4; the disease is graft versus host disease.